Satoko Fujieda, Mitsuaki Keira, M. Soma, Yoichi Sasaki, A. Konda, Yuji Mukai, T. Toda, N. Inotsume, H. Yoshida
{"title":"双胞胎母亲及其新生儿双胞胎停用利托卡因","authors":"Satoko Fujieda, Mitsuaki Keira, M. Soma, Yoichi Sasaki, A. Konda, Yuji Mukai, T. Toda, N. Inotsume, H. Yoshida","doi":"10.3999/JSCPT.48.91","DOIUrl":null,"url":null,"abstract":"- 94 Abstract This study aimed to clarify the individual elimination kinetics of serum ritodrine in women pregnant with twins and their twin neonates. Serum ritodrine concentrations in 10 twin pregnant women and their twin neonates were measured by liquid chro-matography-tandem mass spectrometry ( LC - MS / MS ) using 100 m L of serum. The ritodrine elimination half-life in mothers was 5 . 0 ± 2 . 2 ( 3 . 7 - 11 . 1 ) h [ mean ± SD ( range )] , while the half-lives of ritodrine in the first and second newborns were 9 . 0 ± 8 . 4 ( 4 . 2 - 29 . 6 ) and 7 . 2 ± 4 . 3 ( 4 . 3 - 13 . 2 ) h, respectively. Large individual differences in the half-life of ritodrine were observed in both mothers and their newborns. Since ritodrine remained in newborn serum for 24 - 48 h after birth, newborns need to be carefully monitored for ritodrine-related complications during","PeriodicalId":21491,"journal":{"name":"Rinsho Yakuri\\/japanese Journal of Clinical Pharmacology and Therapeutics","volume":"19 1","pages":"91-94"},"PeriodicalIF":0.0000,"publicationDate":"2017-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Elimination of Ritodrine in Mothers Pregnant with Twins and Their Neonatal Twins\",\"authors\":\"Satoko Fujieda, Mitsuaki Keira, M. Soma, Yoichi Sasaki, A. Konda, Yuji Mukai, T. Toda, N. Inotsume, H. Yoshida\",\"doi\":\"10.3999/JSCPT.48.91\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"- 94 Abstract This study aimed to clarify the individual elimination kinetics of serum ritodrine in women pregnant with twins and their twin neonates. Serum ritodrine concentrations in 10 twin pregnant women and their twin neonates were measured by liquid chro-matography-tandem mass spectrometry ( LC - MS / MS ) using 100 m L of serum. The ritodrine elimination half-life in mothers was 5 . 0 ± 2 . 2 ( 3 . 7 - 11 . 1 ) h [ mean ± SD ( range )] , while the half-lives of ritodrine in the first and second newborns were 9 . 0 ± 8 . 4 ( 4 . 2 - 29 . 6 ) and 7 . 2 ± 4 . 3 ( 4 . 3 - 13 . 2 ) h, respectively. Large individual differences in the half-life of ritodrine were observed in both mothers and their newborns. Since ritodrine remained in newborn serum for 24 - 48 h after birth, newborns need to be carefully monitored for ritodrine-related complications during\",\"PeriodicalId\":21491,\"journal\":{\"name\":\"Rinsho Yakuri\\\\/japanese Journal of Clinical Pharmacology and Therapeutics\",\"volume\":\"19 1\",\"pages\":\"91-94\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-05-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rinsho Yakuri\\\\/japanese Journal of Clinical Pharmacology and Therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3999/JSCPT.48.91\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rinsho Yakuri\\/japanese Journal of Clinical Pharmacology and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3999/JSCPT.48.91","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
摘要本研究旨在阐明双胞胎孕妇及其双胞胎新生儿血清利托卡因的个体消除动力学。采用液相色谱-串联质谱法(LC - MS / MS)测定了10例双胞胎孕妇及其双胞胎新生儿的血清利托碱浓度。利托卡因在母亲体内的消除半衰期为5年。0±2。2);7 - 11。1) h [mean±SD (range)],而利托君在第一、二胎的半衰期分别为9。0±8。4 . b。2 - 29。6)和7。2±4。3 (4);3 - 13。2) h,分别。在母亲和新生儿中观察到利托卡因半衰期的巨大个体差异。由于利托卡因在出生后24 - 48小时仍存在于新生儿血清中,因此需要在分娩过程中仔细监测新生儿是否有利托卡因相关并发症
Elimination of Ritodrine in Mothers Pregnant with Twins and Their Neonatal Twins
- 94 Abstract This study aimed to clarify the individual elimination kinetics of serum ritodrine in women pregnant with twins and their twin neonates. Serum ritodrine concentrations in 10 twin pregnant women and their twin neonates were measured by liquid chro-matography-tandem mass spectrometry ( LC - MS / MS ) using 100 m L of serum. The ritodrine elimination half-life in mothers was 5 . 0 ± 2 . 2 ( 3 . 7 - 11 . 1 ) h [ mean ± SD ( range )] , while the half-lives of ritodrine in the first and second newborns were 9 . 0 ± 8 . 4 ( 4 . 2 - 29 . 6 ) and 7 . 2 ± 4 . 3 ( 4 . 3 - 13 . 2 ) h, respectively. Large individual differences in the half-life of ritodrine were observed in both mothers and their newborns. Since ritodrine remained in newborn serum for 24 - 48 h after birth, newborns need to be carefully monitored for ritodrine-related complications during